May 22, 2018 / 12:49 PM / in a month

BRIEF-Allergan Exercises Option To Acquire Compound From Aptinyx Discovery Platform

May 22 (Reuters) - Allergan plc:

* ALLERGAN EXERCISES OPTION TO ACQUIRE COMPOUND FROM APTINYX DISCOVERY PLATFORM UNDER ONGOING RESEARCH COLLABORATION

* APTINYX - ALLERGAN EXERCISED OPTION TO ACQUIRE DRUG CANDIDATE AGN-241751, AN ORAL SMALL-MOLECULE N-METHYL-D-ASPARTATE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below